Nuzenio

Halozyme Therapeutics

Halozyme Therapeutics news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 12 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 16:12:05 GMTIs Halozyme Therapeutics (HALO) Fairly Valued As Earnings Beat And Guidance Rise? - Yahoo Finance Singapore
Sat, 08 Aug 2026 14:36:47 GMTHalozyme (HALO) Stock Rallies As Royalties Surge And Guidance Climbs - simplywall.st
Sat, 08 Aug 2026 07:55:11 GMTHalozyme Therapeutics (NASDAQ:HALO) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Sat, 08 Aug 2026 06:48:42 GMTHalozyme Therapeutics (HALO) Shares Skyrocket, What You Need To Know - StockStory
Sat, 08 Aug 2026 03:06:00 GMTHalozyme Therapeutics Inc (HALO) (Q2 2026) Earnings Call Highlights: Record Revenue and Royalty ... - Yahoo Finance
Fri, 07 Aug 2026 21:22:29 GMTHalozyme Therapeutics (NASDAQ:HALO) Given New $105.00 Price Target at TD Cowen - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Halozyme Therapeutics.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

12 distinct publisher/source names are currently connected to this entity page.